Nong Shang

发表

Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 202

R. Link-Gelles, J. Verani, Emma K. Accorsi, 2023, Morbidity and Mortality Weekly Report.